✦ LIBER ✦

Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance

✍ Scribed by Smith, Mitchell R

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunotherapeutic mechanisms of anti-CD2

✍ Ronald P Taylor; Margaret A Lindorfer 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 364 KB

Mechanism of action on B cell lymphoma b

✍ Oyama, T; Kagami, Y; Seto, M; Morishima, Y 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 68 KB

SLE-associated transverse myelitis succe

✍ D. J. Armstrong; M. T. McCarron; G. D. Wright 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 122 KB

Successful Treatment of Refractory Child

✍ Heidi H. Kong; Neil S. Prose; Russell E. Ware; Russell P. Hall III 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

Rituximab chimeric anti-CD20 monoclonal

✍ Peter Brændstrup; Ole W. Bjerrum; Ove J. Nielsen; Bjarne A. Jensen; Nielsaage T. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 2 views

Treatment of refractory fludarabine indu

✍ R. SWORDS; A. NOLAN; M. FAY; J. QUINN; R. O'DONNELL; P. T. MURPHY 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB